| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A clinical review of bleeding dilemmas in trauma
|
Hoyt, David B
|
|
2004
|
41 |
S1 |
p. 40-43
4 p.
|
artikel
|
| 2 |
Bleeding complications after hematopoietic stem cell transplantation
|
Pihusch, Markus
|
|
2004
|
41 |
S1 |
p. 93-100
8 p.
|
artikel
|
| 3 |
Challenges for providing effective hemostasis in surgery and trauma
|
Lawson, Jeffrey H
|
|
2004
|
41 |
S1 |
p. 55-64
10 p.
|
artikel
|
| 4 |
Current and future challenges of antithrombotic agents and anticoagulants: strategies for reversal of hemorrhagic complications
|
Kessler, Craig M
|
|
2004
|
41 |
S1 |
p. 44-50
7 p.
|
artikel
|
| 5 |
Dose optimization of recombinant factor VIIa for control of mild to moderate bleeds in inhibitor patients: improved efficacy with higher dosing
|
Abshire, Thomas C
|
|
2004
|
41 |
S1 |
p. 3-7
5 p.
|
artikel
|
| 6 |
Dosing with recombinant factor viia based on current evidence
|
Hedner, Ulla
|
|
2004
|
41 |
S1 |
p. 35-39
5 p.
|
artikel
|
| 7 |
Early predictors of outcome in trauma patients
|
Lynn, Mauricio
|
|
2004
|
41 |
S1 |
p. 175-
1 p.
|
artikel
|
| 8 |
Elective orthopedic surgery for hemophilia patients with inhibitors: new opportunities
|
Rodriguez-Merchan, E.Carlos
|
|
2004
|
41 |
S1 |
p. 109-116
8 p.
|
artikel
|
| 9 |
Emerging risks and outcomes of blood transfusion in surgery
|
Shander, Aryeh
|
|
2004
|
41 |
S1 |
p. 117-124
8 p.
|
artikel
|
| 10 |
Environmental and genetic factors influencing inhibitor development 1 1 Portions of this work have been previously published in Rodriquez-Merchan C, Goddard N, Lee C: Musculoskeletal Aspects of Haemophilia. Blackwell Science Publishing, 2000.
|
Oldenburg, Johannes
|
|
2004
|
41 |
S1 |
p. 82-88
7 p.
|
artikel
|
| 11 |
Epidemiological basis for future improvements in trauma care
|
Champion, Howard R.
|
|
2004
|
41 |
S1 |
p. 173-
1 p.
|
artikel
|
| 12 |
Excluded abstracts
|
|
|
2004
|
41 |
S1 |
p. 176-
1 p.
|
artikel
|
| 13 |
Experiences with recombinant human factor VIIa in patients with thrombocytopenia
|
Goodnough, Lawrence Tim
|
|
2004
|
41 |
S1 |
p. 25-29
5 p.
|
artikel
|
| 14 |
Factor XI deficiency
|
O’Connell, Niamh M
|
|
2004
|
41 |
S1 |
p. 76-81
6 p.
|
artikel
|
| 15 |
Hemostasis in liver resection surgery
|
Lodge, J.Peter A
|
|
2004
|
41 |
S1 |
p. 70-75
6 p.
|
artikel
|
| 16 |
Introduction
|
Roberts, Harold R.
|
|
2004
|
41 |
S1 |
p. 1-2
2 p.
|
artikel
|
| 17 |
Management of gastrointestinal bleeding in patients with cirrhosis of the liver
|
Bosch, Jaime
|
|
2004
|
41 |
S1 |
p. 8-12
5 p.
|
artikel
|
| 18 |
Monitoring coagulation and the clinical effects of recombinant factor VIIa
|
Gabriel, Don A
|
|
2004
|
41 |
S1 |
p. 20-24
5 p.
|
artikel
|
| 19 |
New alternatives for control of severe cardiac surgical bleeding
|
Gill, Ravi
|
|
2004
|
41 |
S1 |
p. 174-
1 p.
|
artikel
|
| 20 |
New insights into factors affecting clot stability: a role for thrombin activatable fibrinolysis inhibitor (TAFI; plasma procarboxypeptidase B, plasma procarboxypeptidase U, procarboxypeptidase R)
|
Bouma, Bonno N
|
|
2004
|
41 |
S1 |
p. 13-19
7 p.
|
artikel
|
| 21 |
Novel hemostatic alternatives in reconstructive surgery
|
Waner, Milton
|
|
2004
|
41 |
S1 |
p. 163-167
5 p.
|
artikel
|
| 22 |
Platelet membrane fragments enhance the procoagulant effect of recombinant factor VIIa in studies with circulating human blood under conditions of experimental thrombocytopenia
|
Tonda, Raúl
|
|
2004
|
41 |
S1 |
p. 157-162
6 p.
|
artikel
|
| 23 |
Recombinant factor VIIa as an antidote for anticoagulant treatment
|
Levi, Marcel
|
|
2004
|
41 |
S1 |
p. 65-69
5 p.
|
artikel
|
| 24 |
Safety profile of recombinant factor VIIa
|
Roberts, Harold R
|
|
2004
|
41 |
S1 |
p. 101-108
8 p.
|
artikel
|
| 25 |
Strategies for minimizing blood loss in orthopedic surgery
|
Tobias, Joseph D
|
|
2004
|
41 |
S1 |
p. 145-156
12 p.
|
artikel
|
| 26 |
The management of coagulopathy and blood loss in liver surgery
|
Silva, Michael A
|
|
2004
|
41 |
S1 |
p. 132-139
8 p.
|
artikel
|
| 27 |
The use of recombinant factor VIIa in head injury: a report of five cases
|
Zaaroor, Menashe
|
|
2004
|
41 |
S1 |
p. 175-176
2 p.
|
artikel
|
| 28 |
Thromboelastography and recombinant factor VIIa—hemophilia and beyond
|
Sørensen, B
|
|
2004
|
41 |
S1 |
p. 140-144
5 p.
|
artikel
|
| 29 |
Tissue factor as an evolutionary conserved cytokine receptor: implications for inflammation and signal transduction
|
Versteeg, Henri H
|
|
2004
|
41 |
S1 |
p. 168-172
5 p.
|
artikel
|
| 30 |
Understanding the hemostatic effects of recombinant factor VIIa by clot wave form analysis
|
Shima, Midori
|
|
2004
|
41 |
S1 |
p. 125-131
7 p.
|
artikel
|
| 31 |
Variants of recombinant factor VIIa with increased intrinsic activity
|
Persson, Egon
|
|
2004
|
41 |
S1 |
p. 89-92
4 p.
|
artikel
|
| 32 |
Vascular biology—the role of tissue factor
|
Hathcock, James
|
|
2004
|
41 |
S1 |
p. 30-34
5 p.
|
artikel
|
| 33 |
Views on methods for monitoring recombinant factor VIIa in inhibitor patients
|
Key, Nigel S
|
|
2004
|
41 |
S1 |
p. 51-54
4 p.
|
artikel
|
Tijdschrift beschrijving